Unibest
← Back to patent-cliff list

CAS 501-97-3

3-(4-Hydroxyphenyl)propionic acid3-(4-hydroxyphenyl)propanoic acid

Codes: (VII)828549-1-b, LAND-004

Application context (from source-drug indications)

Prostate cancerTLX-591 companion diagnostic (Telix Pharmaceuticals)Diagnostic agentTLX-591 companion diagnostic (Telix Pharmaceuticals)Castration-resistant prostate cancerTLX-591 companion diagnostic (Telix Pharmaceuticals)Hepatocellular carcinomaTLX-591 companion diagnostic (Telix Pharmaceuticals)Castration-sensitive prostate cancerTLX-591 companion diagnostic (Telix Pharmaceuticals)Bladder cancerTLX-591 companion diagnostic (Telix Pharmaceuticals)Supraventricular tachycardiaLandiolol Hydrochloride室性心律失常Landiolol HydrochlorideArrhythmiaLandiolol Hydrochloride窦性心动过速Landiolol HydrochlorideAtrial fibrillationLandiolol HydrochlorideAtrial flutterLandiolol Hydrochloride

Source drugs (routes using this intermediate)

DrugTierExpiry
TLX-591 companion diagnostic (Telix Pharmaceuticals)Tier C — Watch / trade-
Landiolol HydrochlorideTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.